CD4 and neoplasm: Although validation is needed from analyses such as Luminex-based cytokine/chemokine levels in ascites, the elevated expression of regulatory T cells (CD4+FoxP3+) in patients with a good prognosis (Clusters B, C, and D; S2 Fig) may indicate that these cells play a role in suppressing tumor-promoting inflammation.